Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Patterson Companies explores strategic options amidst mixed Q2 performance

Patterson Companies navigated Q2 with a focus on cost management, strategic investments, and long-term growth. The company faces challenges in the Dental segment but sees opportunities in maximizing shareholder value and leveraging stable patient traffic.
Despite headwinds in equipment sales, Patterson Companies remains committed to efficiency optimization and margin enhancement, positioning itself for sustained growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Here is how Patterson Cos. (PDCO) and Abcam PLC Sponsored ADR (ABCM) have performed compared to their sector so far this year.

Is Patterson Companies (PDCO) Stock Outpacing Its Medical Peers This Year?

Phillips 66

Telephone and Data Systems

As contrarian investors, we have no desire to buy the stock market while it's hot. We wait for it to cool off.

Breakouts Or Fakeouts? 3 Dividends With Fresh 52-Week Highs

Investors are optimistic about Patterson Companies' (PDCO) broad product line.

Patterson Companies (PDCO) Hits 52-Week High: What's Aiding It?

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

Reasons to Add Patterson Companies (PDCO) to Your Portfolio Now

Definitive Healthcare Corp

Neogen

Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how NEOG, PDCO and DH are poised ahead of their earnings release.

3 Medical Product Stocks Set to Outpace Q2 Earnings Estimates

Patterson Cos. (PDCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Patterson Cos. (PDCO) is Poised to Beat Earnings Estimates Again

Patterson Cos. (PDCO) reported earnings 30 days ago.

Patterson Cos. (PDCO) Up 3.5% Since Last Earnings Report: Can It Continue?

From a technical perspective, Patterson Cos. (PDCO) is looking like an interesting pick, as it just reached a key level of support.

Patterson Cos. (PDCO) Just Flashed Golden Cross Signal: Do You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Patterson Cos. (PDCO) is a Top-Ranked Value Stock: Should You Buy?

Align Technology

Cooper Companies

West Pharmaceutical Services

DENTSPLY SIRONA

Here we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, ALGN, COO, XRAY and PDCO.

5 Stocks to Buy From the Prospering Dental Supplies Industry

GlaxoSmithKline

Perrigo

Finding a qualified financial advisor doesn't have to be hard. SmartAsset's free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes.

3 Healthcare Stocks to Buy Amid Market Volatility

Medtronic

Merit Medical Systems

Patterson Companies and Medtronic have above-average dividends. Merit Medical Systems and Medtronic have been active in growing revenue through acquisitions.

3 Top Healthcare Stocks to Buy for July

Ford Motor Company

Nexstar Media Group

Suzano S.A. - ADR

With the increased uncertainty around further rate hikes, it's best to select stocks that re sure to shine in the long term.

4 Strong Buy Stocks with Attractive Long-Term Prospects

KB Home

Today we use a Zacks screen that helps find stocks that offer a combination of value and improving earnings outlooks for investors looking to buy stocks in July and beyond.

Finding Top-Ranked Value Stocks to Buy in July

Eagle Materials

ABB Ltd.

Invest in companies like GMS (GMS), ABB (ABBNY), Eagle Materials (EXP) and Patterson Companies (PDCO) that are powered by higher efficiency levels.

4 Stocks Backed by High Efficiency to Boost Portfolio Returns

Afya Ltd

Greif

Toll Brothers

Here are the five stocks that fit our screening criteria, TOL, PDCO, GEF, NXST and AFYA.

5 Best PEG-Driven GARP Stocks for Investors

Patterson Companies Inc. ( PDCO , Financial) is a multinational corporation that provides products, technologies, services and solutions for the dental and animal health markets.

Patterson Companies Offers Value

Patterson Cos. (PDCO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices.

Patterson Cos. (PDCO) Is Attractively Priced Despite Fast-paced Momentum

The animal care and dental healthcare specialist delivered its latest set of quarterly results. The bottom-line earnings beat was particularly impressive.

Why Patterson Companies Stock Was Riding High This Week

Patterson Companies, Inc. NASDAQ: PDCO is a dual-story that includes healthcare for humans and animals. The company operates in 2 segments, Dental and Animal Health, and both are growing.

Patterson Companies Leverages Healthcare For Income Investors

The company saw revenue and earnings per share rise over 2021 and over the fourth quarter of 2022. Its dental segment had the biggest sales increase in the quarter, up 8%, year over year.

Why Shares of Patterson Companies Shot Up Wednesday

Patterson Companies' (PDCO) fiscal fourth-quarter 2023 results reflect robust improvement in Dental Equipment sales, Value-added services and Animal Health segment.

Patterson Companies (PDCO) Q4 Earnings Beat, Sales Hurt by FX

Patterson Companies, Inc. (NASDAQ:PDCO ) Q4 2023 Earnings Call Transcript June 21, 2023 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Michael Cherny - Bank of America Nathan Rich - Goldman Sachs Jonathan Block - Stifel Nicolaus Jeff Johnson - Robert W. Baird Elizabeth Anderson - Evercore ISI Kevin Caliendo - UBS Brandon Vazquez - William Blair A.J.

Patterson Companies, Inc. (PDCO) Q4 2023 Earnings Call Transcript

PDCO stock rocketed nearly 15% Wednesday after pet, dental supplies maker Patterson topped Q4 views, provided a solid earnings outlook.

PDCO Stock Spikes After Pet, Dental Supplies Maker Beats Earnings

Patterson Companies, Inc shares jumped 15% to $32.40 in early Wednesday trading after the dental and animal health company reported fourth quarter 2023 revenue that rose 5% year over year to $1.72 billion, surpassing the FactSet consensus estimate of $1.66 billion. Patterson also generated $0.84 in adjusted earnings per share (EPS) during the quarter, topping the consensus analyst forecast of $0.70, as margins expanded and sales in its two primary segments, Dental and Animal Health, accelerated.

News for Patterson Companies Stock (PDCO)